Since JQ1 selected for a CD44high/LUM+ phenotype in CRC cells, and HSP90i decreased the amount of CD142high cells in CAF cultures, furthermore, both CRC cells and CAFs were sensitive to BCLi, thus, the combination of BCLi and HSP90i may represent a novel effective combination. The gene discussed is LUM; the disease is colorectal carcinoma.